Synopsis

A remarkable new technology, CRISPR, has given us the ability to alter DNA—even within the human genome. Yet, the question remains: where do we draw the line? Gene editing offers the potential to eradicate debilitating genetic diseases like sickle cell anemia. However, these possibilities swiftly give rise to profound ethical dilemmas. Is it justifiable to engineer soldiers to be impervious to pain, or to attempt the resurrection of species lost to time?